background
antimicrobi
resist
increasingli
recogn
global
challeng
studi
emerg
epidemiolog
multidrug
resist
organ
tertiari
care
set
arabian
gulf
aim
describ
epidemiolog
multidrug
resist
organ
mdro
sultan
qaboo
univers
hospit
tertiari
hospit
oman
method
retrospect
review
mdro
record
conduct
throughout
period
januari
till
decemb
organ
identifi
test
autom
identif
suscept
system
antibiot
suscept
test
confirm
disk
diffus
method
result
total
admiss
patient
regist
mdro
patient
give
overal
preval
rate
ci
mdro
case
per
admiss
addit
preval
rate
mdro
isol
ci
per
admiss
overal
increas
trend
preval
rate
mdro
patient
mdro
isol
observ
throughout
studi
period
conclus
antimicrobi
resist
emerg
challeng
oman
continu
monitor
antimicrobi
suscept
strict
adher
infect
prevent
guidelin
essenti
prevent
prolifer
mdro
along
quest
stringent
antibiot
prescript
guidelin
need
countri
data
emerg
differ
part
world
suggest
strain
highli
multidrug
resist
organ
mdro
quadrupl
past
decad
mdro
increasingli
recogn
impervi
avail
antibiot
mdro
afflict
vulner
individu
risk
morbid
mortal
heighten
insidi
neg
repercuss
includ
lengthen
hospit
stay
increas
social
medic
cost
due
emerg
mdro
prior
turn
centuri
among
healthcar
planner
enthusiasm
health
year
retrospect
farfetch
aspir
bare
two
decad
new
centuri
prolifer
infecti
diseas
render
standard
public
health
mani
part
world
equival
preantibiot
era
like
myriad
factor
contribut
rise
tide
nosocomi
infect
firstli
mani
attempt
find
altern
mean
includ
bacteriophag
immuneenhanc
strategi
found
practic
adjunct
antibiot
secondli
develop
new
gener
antibiot
hamper
exist
regul
amen
develop
new
antibiot
lack
scientif
strategi
develop
new
class
antibiot
reason
long
lull
develop
new
antibiot
critic
also
argu
pharmaceut
scientif
world
journal
compani
littl
incent
invest
could
enorm
costli
ventur
develop
new
antibiot
profit
margin
newli
develop
antibiot
lower
compar
lifestyl
medic
thirdli
strong
indic
global
prolifer
strain
multidrug
resist
bacteria
may
partli
stem
fact
pervas
overus
misus
antimicrobi
agent
univers
call
judici
use
antimicrobi
agent
messag
appear
unheed
emerg
variou
strain
intract
antibiot
resist
organ
appear
prolifer
differ
part
world
fourthli
present
prolifer
differ
strain
multidrug
resist
organ
limit
overus
human
also
signific
contribut
antibiot
resist
organ
food
suppli
due
overuseabus
antibiot
treatment
prevent
growth
promot
anim
yet
feasibl
strategi
reduc
antibioticresist
organ
enter
food
chain
age
global
advanc
transport
telecommun
infrastructur
increas
crosscultur
technolog
interchang
aid
diffus
organ
one
region
anoth
also
creat
fertil
ground
internation
multidrug
resist
bacteria
oman
countri
southern
tip
arabian
peninsula
overlook
contin
asia
africa
repres
place
global
arabia
intertwin
accord
censu
popul
estim
countri
classifi
world
bank
highincom
economi
among
emerg
economi
recent
affluenc
due
exploit
hydrocarbon
turn
oman
hub
intern
shipment
trade
countri
attract
number
foreign
worker
differ
part
world
consequ
may
entail
term
human
anim
materi
exchang
testifi
infect
link
zoonot
event
preliminari
studi
allud
exist
mdro
year
almuharrmi
et
al
evalu
extendedspectrum
lactamas
esbl
isol
pediatr
popul
oman
period
observ
author
found
e
coli
klebsiella
pneumonia
isol
esbl
produc
studi
conclud
esblproduc
organ
becom
major
problem
omani
children
refer
pediatr
popul
almuharrmi
colleagu
also
investig
vitro
activ
carbapenem
piperacillintazobactam
ciprofloxacin
alon
combin
aminoglycosid
esblproduc
strain
isol
clinic
sampl
found
esbl
high
resist
profil
piperacillintazobactam
ciprofloxacin
studi
conclud
esbl
oman
similar
resist
pattern
report
uk
usa
studi
region
also
point
emerg
multidrug
resist
organ
recent
ali
balkhi
synthes
prevail
situat
region
review
publish
articl
nosocomi
infect
author
identifi
total
articl
publish
whole
review
indic
emerg
mdro
accordingli
escherichia
coli
klebsiella
pneumonia
pseudomona
aeruginosa
methicillinresist
staphylococcu
aureu
acinetobact
c
difficil
enterococcu
exist
region
variabl
rate
strain
mdro
studi
focus
one
particular
subspecialti
clinic
depart
studi
need
garner
comprehens
view
exampl
tertiari
care
hospit
attende
hospit
like
advanc
patholog
diseas
highli
immunocompromis
therefor
prone
succumb
vagari
mdro
therefor
explor
epidemiolog
type
multidrug
resist
organ
tertiari
care
imper
oman
repres
fertil
ground
undertak
knowledg
previou
comprehens
document
mdro
oman
order
consolid
avail
inform
mdro
tertiari
care
set
oman
studi
aim
address
monthli
cumul
frequenc
preval
rate
hospitalacquir
multidrug
resist
organ
year
also
aim
describ
distribut
hospitalacquir
mdro
site
infect
type
bacteria
retrospect
review
conduct
report
gramneg
gramposit
isol
unit
squh
tertiari
care
teach
hospit
muscat
oman
studi
conduct
period
januari
decemb
gramneg
gramposit
organ
identifi
test
definit
mdro
base
recent
propos
joint
definit
european
center
diseas
prevent
control
ecdc
center
diseas
prevent
control
cdc
two
preval
rate
calcul
preval
rate
mdro
patient
preval
rate
mdro
isol
preval
rate
calcul
divid
number
case
index
number
monthli
inpati
admiss
whole
year
preval
rate
report
per
admiss
confid
interv
ci
preval
rate
calcul
use
poisson
distribut
method
binomi
variabl
ci
calcul
use
graphpad
prism
softwar
trend
preval
rate
period
calcul
analyz
identifi
statist
signific
increas
decreas
trend
use
cochranarmitag
test
trend
cutoff
valu
statist
signific
taken
valu
statist
packag
social
scienc
spss
version
ibm
use
statist
analys
ethic
approv
studi
obtain
institut
review
board
sultan
qaboo
univers
medic
research
ethic
committe
colleg
medicin
health
scienc
tabl
show
cumul
frequenc
rate
hospitalacquir
mdro
among
patient
isol
scientif
world
journal
shown
figur
preval
rate
mdro
patient
isol
rel
steadi
throughout
period
januari
august
septemb
abrupt
increas
preval
rate
continu
elev
end
year
overal
increas
trend
preval
rate
mdro
patient
mdro
isol
found
statist
signific
trend
resp
tabl
depict
bloodstream
infect
pneumonia
frequent
occur
infect
caus
hospitalacquir
mdro
resp
follow
urinari
tract
infect
uti
surgic
infect
encount
among
mdro
affect
patient
illustr
tabl
number
type
bacteria
nine
name
acinetobact
baumannii
methicillinresist
aureu
mrsa
escherichia
coli
escherichia
coli
cre
klebsiella
pneumina
klebsiella
pneumonia
esbl
enterobact
pseudomona
enterococcu
vre
burkholderia
stenotrophomona
maltophilia
acinetobact
baumannii
preval
mdro
among
isol
e
coli
come
next
percentag
follow
methicillinresist
aureu
mrsa
klebsiella
pneumonia
esbl
frequenc
pseudomona
aeruginosa
klebsiella
pneumonia
cre
stenotrophomona
maltophilia
nearli
equal
resp
rest
encount
frequenc
less
estim
nosocomi
infect
annual
contract
around
two
million
north
america
signific
number
requir
critic
care
colon
mdro
tend
unexpectedli
high
rate
scientif
world
journal
morbid
mortal
social
econom
medic
cost
nosocomi
infect
mount
huge
financi
cost
situat
limit
north
america
preliminari
studi
indic
healthcareassoci
infect
constitut
global
challeng
gcc
countri
previou
survey
omani
healthcareassoci
infect
limit
specif
clinic
popul
knowledg
studi
first
kind
comprehens
explor
monthli
variat
preval
rate
site
infect
type
mdro
tertiari
care
hospit
first
hypothesi
regard
monthli
variat
averag
admiss
approxim
patient
mdro
approxim
isol
suggest
afflict
individu
one
organ
strong
indic
climat
factor
tend
influenc
rate
nosocomi
infect
studi
indic
nosocomi
infect
invari
affect
weather
studi
healthcareassoci
infect
shown
tend
dwindl
summer
support
summer
season
normal
peak
april
septemb
appear
associ
fewer
incid
healthcareassoci
infect
find
would
withstand
scrutini
countermeasur
mitig
healthcareassoci
infect
consid
factor
monthli
variat
climat
condit
infect
like
occur
second
relat
aim
studi
gaug
preval
rate
hospitalacquir
multidrug
resist
organ
overal
preval
rate
mdro
patient
found
per
admiss
consider
variat
report
preval
estim
mdro
worldwid
rang
per
admiss
despit
report
document
increas
trend
last
year
preval
mdro
report
studi
per
admiss
fall
within
intern
rang
estim
preval
great
import
provid
health
author
reliabl
data
plan
adequ
health
care
measur
studi
indic
increas
trend
throughout
month
observ
addit
climat
condit
increas
preval
mdro
link
antimicrobi
use
inadequ
antimicrobi
therapi
long
antimicrobi
exposur
may
trigger
emerg
resist
bacterium
previous
amen
antibiot
strong
evid
suggest
contamin
healthcar
worker
hand
environment
surfac
may
play
role
exacerb
mdro
factor
associ
mdro
includ
gender
underli
comorbid
well
expos
medic
gadget
cross
differ
anatom
site
breach
bodi
natur
physic
barrier
mechan
ventil
cathet
third
aim
studi
quantifi
distribut
site
infect
particular
tertiari
care
commonest
site
mdro
infect
bloodstream
pneumonia
elsa
et
al
report
common
site
studi
saudi
intens
care
unit
tertiari
hospit
mdro
respiratori
blood
similar
pattern
observ
countri
includ
itali
finland
howev
studi
point
differ
distribut
site
mdro
infect
exampl
jaggi
trace
bacteri
cultur
period
month
tertiari
care
hospit
haryana
india
found
mdro
isol
mostli
urin
cultur
constitut
total
bacteri
cultur
although
emerg
mdro
global
phenomenon
like
across
popul
geograph
variat
therefor
surpris
oman
rate
mdro
appear
monthli
variat
final
relat
aim
studi
survey
commonest
type
mdro
decad
research
identifi
variou
common
multidrug
resist
organ
includ
vancomycinresist
enterococci
mrsa
klebsiella
pneumonia
carbapenemas
produc
gramneg
enterococcu
faecium
staphylococcu
aureu
acinetobact
baumannii
well
fall
broad
categori
multidrug
resist
gramneg
rod
common
mdro
relat
enterobact
speci
acinetobact
baumannii
report
array
organ
studi
similar
studi
conduct
theregion
attempt
review
preval
antibiot
resist
gcc
countri
reason
behind
phenomenon
ali
balkhi
report
preval
microorgan
e
coli
follow
k
pneumonia
p
aeruginosa
mrsa
acinetobact
found
less
frequent
observ
nearli
equal
percentag
resp
previou
studi
done
patient
admit
icu
riyadh
militari
hospit
saudi
arabia
similar
isol
obtain
among
acinetobact
baumannii
common
mdro
saudi
arabia
also
el
tahawi
khalaf
evalu
isol
found
p
aeruginosa
k
pneumonia
e
coli
enterobact
commonli
isol
imipenem
ciprofloxacin
amikacin
show
greatest
efficaci
anoth
studi
carri
tertiari
care
hospit
riyadh
scientif
world
journal
oneyear
period
show
frequent
pathogen
p
aeruginosa
e
coli
aureu
k
pneumonia
marcescen
studi
without
limit
singl
center
studi
data
may
reflect
mdro
preval
trend
oman
whole
therefor
multisit
studi
would
essenti
order
lay
groundwork
comparison
differ
healthcar
set
anoth
limit
lack
certainti
clinic
specimen
repres
activ
infect
isol
may
repres
activ
infect
patient
addit
correl
sampl
admiss
data
patientclin
specimen
unabl
provid
accur
descript
commun
versu
nosocomi
onset
infect
studi
robust
methodolog
would
need
order
gener
present
find
conclus
studi
demonstr
increas
trend
mdro
oman
array
organ
similar
report
neighbor
countri
find
call
prompt
necess
develop
nationwid
antibiot
polici
guidelin
essenti
nowaday
due
increas
resist
pattern
addit
call
develop
local
antibiogram
databas
improv
knowledg
antimicrobi
resist
pattern
oman
also
help
improv
treatment
strategi
base
unitspecif
data
